Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123906002 | 12390600 | 2 | F | 20160802 | 20160520 | 20160819 | EXP | FR-WARNER CHILCOTT, LLC-1052564 | WARNER CHILCOTT | 49.00 | YR | F | Y | 51.14000 | KG | 20160819 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123906002 | 12390600 | 1 | PS | ACTONEL | RISEDRONATE SODIUM | 1 | Oral | 20835 | 35 | MG | TABLET | ||||||||
| 123906002 | 12390600 | 2 | SS | CORTANCYL | PREDNISONE | 1 | 0 | 20 | MG | ||||||||||
| 123906002 | 12390600 | 3 | SS | HYDROCORTISONE ROUSSEL | HYDROCORTISONE | 1 | Oral | 0 | 15 | MG | |||||||||
| 123906002 | 12390600 | 4 | SS | OROCAL D(3) | CALCIUM CARBONATECHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 123906002 | 12390600 | 5 | SS | DIFFU-K | POTASSIUM CHLORIDE | 1 | Oral | 0 | 600 | MG | |||||||||
| 123906002 | 12390600 | 6 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 123906002 | 12390600 | 7 | SS | TRAMADOL. | TRAMADOL | 1 | Oral | 0 | 50 | MG | |||||||||
| 123906002 | 12390600 | 8 | SS | ZAMUDOL | TRAMADOL HYDROCHLORIDE | 1 | Oral | 0 | 100 | MG | |||||||||
| 123906002 | 12390600 | 9 | SS | ADCIRCA | TADALAFIL | 1 | Oral | 0 | 20 | MG | |||||||||
| 123906002 | 12390600 | 10 | SS | IMOVANE | ZOPICLONE | 1 | Oral | 0 | 7.5 | MG | |||||||||
| 123906002 | 12390600 | 11 | SS | NEFOPAM HYDROCHLORIDE | NEFOPAM HYDROCHLORIDE | 1 | 0 | 20 | MG | ||||||||||
| 123906002 | 12390600 | 12 | SS | ALPRAZOLAM MYLAN | ALPRAZOLAM | 1 | Oral | 0 | .5 | MG | |||||||||
| 123906002 | 12390600 | 13 | SS | COUMADINE | WARFARIN SODIUM | 1 | Oral | 0 | 8 | MG | |||||||||
| 123906002 | 12390600 | 14 | SS | INNOHEP | TINZAPARIN SODIUM | 1 | Subcutaneous | 0 | |||||||||||
| 123906002 | 12390600 | 15 | SS | MABTHERA | RITUXIMAB | 1 | 0 | 1 | G |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123906002 | 12390600 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123906002 | 12390600 | Hypotension | |
| 123906002 | 12390600 | Rash macular | |
| 123906002 | 12390600 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123906002 | 12390600 | 1 | 20160316 | 20160317 | 0 | |
| 123906002 | 12390600 | 2 | 20160317 | 0 | ||
| 123906002 | 12390600 | 3 | 20160317 | 0 | ||
| 123906002 | 12390600 | 4 | 20160316 | 0 | ||
| 123906002 | 12390600 | 5 | 20160317 | 0 | ||
| 123906002 | 12390600 | 6 | 20160317 | 0 | ||
| 123906002 | 12390600 | 7 | 20160419 | 0 | ||
| 123906002 | 12390600 | 8 | 20160425 | 0 | ||
| 123906002 | 12390600 | 9 | 20160422 | 20160427 | 0 | |
| 123906002 | 12390600 | 10 | 20160422 | 0 | ||
| 123906002 | 12390600 | 11 | 20160418 | 0 | ||
| 123906002 | 12390600 | 12 | 20160423 | 0 | ||
| 123906002 | 12390600 | 13 | 20160316 | 20160319 | 0 | |
| 123906002 | 12390600 | 14 | 20160318 | 0 | ||
| 123906002 | 12390600 | 15 | 20160427 | 0 |